Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2020

Open Access 01-12-2020 | Thyroidectomy | Case report

Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection

Authors: Qin Huang, Aihua Hu, Mingsheng Zhang

Published in: BMC Endocrine Disorders | Issue 1/2020

Login to get access

Abstract

Background

Hereditary medullary thyroid carcinoma (MTC) is mainly caused by germline mutations in the RET proto-oncogene, which accounts for 20–30% of all MTC according to foreign studies. However, no English literatures have reported Chinese hereditary MTC. Here, we reported two Chinese brothers with MTC that caused by germline RET mutation.

Case presentation

The younger brother was diagnosed with MTC at 29 years ago and suffered recurrence more than 10 years. For elder brother, the diagnosis of MTC was made by postoperative pathological examination at age 61. Both patients received total thyroidectomy and lymph node dissection. Since they had a significant family history for MTC, genetic detection was performed and identified a germline mutation in RET exon 10 (p.C620Y). This mutation was also detected in their offspring, indicating a moderate risk of MTC.

Conclusions

This is the first report presenting a Chinese family with hereditary MTC caused by the RET p.C620Y variant. This case series emphasize the importance of genetic detection of RET proto-oncogene for MTC patients, and bring out managements for individuals after detection of RET mutations.
Literature
1.
go back to reference Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567–610.CrossRef Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567–610.CrossRef
2.
go back to reference Fagin JA, Wells SA Jr. Biologic and clinical perspectives on thyroid Cancer. N Engl J Med. 2016;375(11):1054–67.CrossRef Fagin JA, Wells SA Jr. Biologic and clinical perspectives on thyroid Cancer. N Engl J Med. 2016;375(11):1054–67.CrossRef
3.
go back to reference Gao Q, Zhang Y, Cheng X, Li Q, Feng Z, Liu Z. Analysis of postoperative survival and prognostic factors for patients with medullary thyroid carcinoma. Chinese J General Surgery. 2018;27(11):1377–86. Gao Q, Zhang Y, Cheng X, Li Q, Feng Z, Liu Z. Analysis of postoperative survival and prognostic factors for patients with medullary thyroid carcinoma. Chinese J General Surgery. 2018;27(11):1377–86.
4.
go back to reference Accardo G, Conzo G, Esposito D, Gambardella C, Mazzella M, Castaldo F, et al. Genetics of medullary thyroid cancer: an overview. Int J Surg. 2017;41(Suppl 1):S2–s6.CrossRef Accardo G, Conzo G, Esposito D, Gambardella C, Mazzella M, Castaldo F, et al. Genetics of medullary thyroid cancer: an overview. Int J Surg. 2017;41(Suppl 1):S2–s6.CrossRef
5.
go back to reference Torresan F, Cavedon E, Mian C, Iacobone M. Long-term outcome after surgery for medullary thyroid carcinoma: a single-center experience. World J Surg. 2018;42(2):367–75.CrossRef Torresan F, Cavedon E, Mian C, Iacobone M. Long-term outcome after surgery for medullary thyroid carcinoma: a single-center experience. World J Surg. 2018;42(2):367–75.CrossRef
6.
go back to reference Lee CR, Lee S, Son H, Ban E, Kang SW, Lee J, et al. Medullary thyroid carcinoma: a 30-year experience at one institution in Korea. Ann Surg Treat Res. 2016;91(6):278–87.CrossRef Lee CR, Lee S, Son H, Ban E, Kang SW, Lee J, et al. Medullary thyroid carcinoma: a 30-year experience at one institution in Korea. Ann Surg Treat Res. 2016;91(6):278–87.CrossRef
7.
go back to reference Rashid MO, Haq N, Farooq S, Kiran Z, Siddique S, Pervez S, et al. Three siblings with familial non-medullary thyroid carcinoma: a case series. J Med Case Rep. 2016;10:213.CrossRef Rashid MO, Haq N, Farooq S, Kiran Z, Siddique S, Pervez S, et al. Three siblings with familial non-medullary thyroid carcinoma: a case series. J Med Case Rep. 2016;10:213.CrossRef
8.
go back to reference Jaggard MK, MacRae C, Ifeacho S, Robinson S, Tolley NS. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation. J Laryngol Otol. 2009;123(7):796–800.CrossRef Jaggard MK, MacRae C, Ifeacho S, Robinson S, Tolley NS. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation. J Laryngol Otol. 2009;123(7):796–800.CrossRef
9.
go back to reference Frilling A, Weber F, Tecklenborg C, Broelsch CE. Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene. Langenbeck's Arch Surg. 2003;388(1):17–26.CrossRef Frilling A, Weber F, Tecklenborg C, Broelsch CE. Prophylactic thyroidectomy in multiple endocrine neoplasia: the impact of molecular mechanisms of RET proto-oncogene. Langenbeck's Arch Surg. 2003;388(1):17–26.CrossRef
10.
go back to reference Yu W, Ning Q, Shi X, Shi R, Ma B, Wen D, et al. Diagnosis and treatment of medullary thyroid cancer. J Cancer Control Treatment. 2019;32(6):475–9. Yu W, Ning Q, Shi X, Shi R, Ma B, Wen D, et al. Diagnosis and treatment of medullary thyroid cancer. J Cancer Control Treatment. 2019;32(6):475–9.
11.
go back to reference Wang J, Zhang B, Yan D, Liu W, Zhengjiang Li XZ. Type of surgery for untreated medullary thyroid carcinoma: a report of 73 cases. Chin J Clin Oncol. 2012;39(7):410–3. Wang J, Zhang B, Yan D, Liu W, Zhengjiang Li XZ. Type of surgery for untreated medullary thyroid carcinoma: a report of 73 cases. Chin J Clin Oncol. 2012;39(7):410–3.
Metadata
Title
Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection
Authors
Qin Huang
Aihua Hu
Mingsheng Zhang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2020
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-020-0544-3

Other articles of this Issue 1/2020

BMC Endocrine Disorders 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.